Khosla Ventures Acquisition (KVSA): Price and Financial Metrics Recent IPO
GET POWR RATINGS... FREE!
KVSA Stock Price Chart Interactive Chart >
KVSA Price/Volume Stats
|Current price||$9.91||52-week high||$10.97|
|Prev. close||$9.90||52-week low||$9.86|
|Day high||$9.93||Avg. volume||369,663|
|50-day MA||$10.21||Dividend yield||N/A|
|200-day MA||$0.00||Market Cap||351.71M|
Khosla Ventures Acquisition (KVSA) Company Bio
Khosla Ventures Acquisition is a newly incorporated blank check company whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities.
KVSA Latest News Stream
|Loading, please wait...|
KVSA Latest Social Stream
View Full KVSA Social Stream
Latest KVSA News From Around the Web
Below are the latest news stories about Khosla Ventures Acquisition Co that investors may wish to consider to help them evaluate KVSA as an investment opportunity.
NEW YORK, June 11, 2021 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies: Khosla Ventures Acquisition Co. (NASDAQ: KVSA) Kholsa Ventures has agreed to merge with Valo Hea
Boston-based Valo Health LLC has agreed to go public through a reverse merger with a blank-check firm backed by venture capitalist Vinod Khosla, in a deal valuing the combined company at about $2.8 billion. Founded in 2019, Valo Health is a biotech company that uses data analysis and artificial intelligence to help drug discovery and development. Valo Health’s platform Opal has a pipeline of candidates across cardiovascular disease, oncology, and neurodegeneration. Its deal with Khosla Ventures
Valo Health and Khosla Ventures Acquisition Co. to Combine and Create Publicly Traded Company Focused on Transforming the Drug Discovery and Development Process
Valo Health, LLC ("Valo"), the technology company using human-centric data and artificial intelligence (AI) powered computation to transform the drug discovery and development process, and Khosla Ventures Acquisition Co. ("KVAC") (NASDAQ: KVSA), a special purpose acquisition company founded by affiliates of Khosla Ventures, LLC, announced today that they have entered into a definitive merger agreement.
KVSA Price Returns